Beaumont Financial Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-625
| Closed | -$8.36K | – | 359 |
|
|
2024
Q2 | $8.36K | Buy |
625
+125
| +25% | +$1.67K | ﹤0.01% | 365 |
|
|
2024
Q1 | $23.2K | Buy |
500
+125
| +33% | +$5.8K | ﹤0.01% | 361 |
|
|
2023
Q4 | $25.4K | Hold |
375
| – | – | ﹤0.01% | 340 |
|
|
2023
Q3 | $27.2K | Hold |
375
| – | – | ﹤0.01% | 322 |
|
|
2023
Q2 | $27.9K | Buy |
375
+50
| +15% | +$3.72K | ﹤0.01% | 341 |
|
|
2023
Q1 | $17.3K | Buy |
325
+25
| +8% | +$1.33K | ﹤0.01% | 314 |
|
|
2022
Q4 | $20.3K | Buy |
300
+25
| +9% | +$1.69K | ﹤0.01% | 313 |
|
|
2022
Q3 | $34K | Buy |
275
+25
| +10% | +$3.09K | ﹤0.01% | 302 |
|
|
2022
Q2 | $24K | Buy |
+250
| New | +$24K | ﹤0.01% | 304 |
|